薬局自動化市場 – 2030年までの世界予測

Report Overview

The global pharmacy automation market is experiencing significant growth in 2024, driven by the increasing incidence of medication errors and the growing need for enhanced patient safety. The market is projected to reach USD 6.65 billion in 2024 from USD 10.00 billion in 2030, expanding at a CAGR of 7.1% from 2024 to 2030.

世界の薬局自動化市場は、投薬ミスの増加と患者の安全性強化のニーズの高まりにより、2024年に大幅な成長を遂げています。市場は2030年の100億ドルから2024年には66億5,000万ドルに達し、2024年から2030年にかけて7.1%のCAGRで拡大すると予測されています。

According to the World Health Organization (WHO), nearly 50% of all medication errors occur during the prescription or ordering process. Additionally, studies indicate that nurses and pharmacists identify between 30% and 70% of medication-ordering errors. Hospitals and pharmacies are increasingly adopting advanced pharmacy automation solutions to mitigate these risks to enhance accuracy, efficiency, and workflow management. This rising demand for automation is expected to accelerate market growth in the coming years.

世界保健機関（WHO）によると、投薬ミスのほぼ50%は処方または発注プロセス中に発生します。さらに、研究によると、看護師と薬剤師は投薬ミスの30%から70%を特定しています。病院や薬局では、これらのリスクを軽減して精度、効率、ワークフロー管理を強化するために、高度な薬局自動化ソリューションを導入するケースが増えています。自動化に対する需要の高まりにより、今後数年間で市場の成長が加速すると予想されます。

Based on type, the robots/robotic automated medication dispensing subsegment accounted for the largest share in automated medication dispensing and storage segment in 2023”

Based on type, the market for automated medication storage and dispensing systems is categorized into robots/robotic automated dispensing systems, carousels, automated dispensing cabinets (ADCs), and others. Robot/robotic automated dispensing systems accounted for the largest share in 2023 of this market. These systems assist in reducing the rate of errors by widening the administration accuracy rate by integrating robots with single/multiple robotic arms that are capable of performing the filling, storing, and dispensing of medications, thereby reducing the chances of manual errors.

“North America dominated the pharmacy automation market in 2023.”

The pharmacy automation market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the pharmacy automation market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing cases of the chronic diseases, rising demand for assisted living and long term care centers and high prescription volume resulting in increased demand of automation in North America market.

Companies such as BD, OMNICELL, McKesson, and Baxter are leading the market by investing in smart, connected pharmacy automation solutions. For instance, in June 2022, BD invested USD 1.525 billion in acquisition of Parata Systems, expanding BD’s footprint in robotic medication dispensing and AI-based workflow automation. This acquisition is expected to accelerate pharmacy automation adoption, particularly in hospitals and centralized prescription fulfillment centers.

The break-down of primary participants is as mentioned below:

• By Company Type – Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation – Directors: 35%, Managers: 40%, and Others: 25%
• By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Oracle (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Mckesson Corporation (US) are some of the key players in the pharmacy automation market.

The study includes an in-depth competitive analysis of these key players in the pharmacy automation market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the pharmacy automation market by product type (automated medication dispensing and storage systems, automated packaging and labeling systems, automated tabletop counters, automated medication compounding systems, pharmacy management software (PMS/PIMS/PIS), and other pharmacy automation systems (pharmacy kiosks, pneumatic tubes, tablet splitters, and others), by component (hardware, software, and service), by application (centralized operations and decentralized operations), by facility type (large-scale pharmacies and small and mid-size pharmacies), and by end-user (hospital pharmacies, ambulatory surgery center (ASC), ambulatory care center (ACC), and other outpatient settings, long-term care facilities & assisted living facilities, retail pharmacies, and pharmacy benefit management organization and mail-order pharmacies) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmacy automation market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the pharmacy automation market. Competitive analysis of upcoming startups in the pharmacy automation market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the pharmacy automation market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (growing need to minimize medication error, decentralization of pharmacies, rising geriatric population leading to increased adoption of automated dispensing systems, growing focus on automation to reduce labor costs, increasing specialty drug dispensing), restraints (high initial capital investments, reluctance to adopt pharmacy automation systems, limited suitability for all medication types, and lack of skilled personnel), opportunities (rising online sales of medicines, expansion of telepharmacy and remote patient management, rising healthcare costs expected to drive the market growth),and challenges (stringent regulatory procedures, risk of cross-contamination, technical failures and system reliability issues, risk of drug name selection errors).

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmacy automation market
• Market Development: Comprehensive information about lucrative markets – the report analyses the pharmacy automation market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmacy automation market

Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Oracle (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Mckesson Corporation (US), among others in the pharmacy automation market.

Table of Contents

1               INTRODUCTION              33

1.1           STUDY OBJECTIVES       33

1.2           MARKET DEFINITION   33

1.3           MARKET SCOPE                34

1.3.1        MARKET SEGMENTATION           34

1.3.2        INCLUSIONS & EXCLUSIONS       35

1.3.3        YEARS CONSIDERED      36

1.3.4        CURRENCY CONSIDERED            36

1.4           LIMITATIONS    37

1.5           STAKEHOLDERS               37

2               RESEARCH METHODOLOGY       39

2.1           RESEARCH DATA              39

2.1.1        SECONDARY DATA          40

2.1.1.1    key data from secondary sources        41

2.1.2        PRIMARY DATA 41

2.1.2.1    Primary sources    42

2.1.2.2    Key data from primary sources           43

2.1.2.3    Key industry insights           44

2.1.2.4    Breakdown of primary interviews      44

2.2           MARKET ESTIMATION METHODOLOGY               45

2.3           MARKET SIZE ESTIMATION         46

2.4           MARKET BREAKDOWN & DATA TRIANGULATION                 53

2.5           RESEARCH ASSUMPTIONS           55

2.5.1        OVERALL STUDY ASSUMPTIONS              55

2.6           RISK ASSESSMENT           56

2.7           RESEARCH LIMITATIONS             56

2.7.1        METHODOLOGY-RELATED LIMITATIONS           56

2.7.2        SCOPE-RELATED LIMITATIONS                 56

3               EXECUTIVE SUMMARY  57

4               PREMIUM INSIGHTS       62

4.1           PHARMACY AUTOMATION MARKET OVERVIEW                 62

4.2           PHARMACY AUTOMATION MARKET, BY END USER AND COUNTRY            63

4.3           PHARMACY AUTOMATION MARKET: GEOGRAPHIC SNAPSHOT          64

4.4           PHARMACY AUTOMATION MARKET: DEVELOPED VS. EMERGING MARKETS    64

5               MARKET OVERVIEW       65

5.1           INTRODUCTION              65

5.2           MARKET DYNAMICS       67

5.2.1        DRIVERS               67

5.2.1.1    Growing need to minimize medication errors 67

5.2.1.2    Decentralization of pharmacies          67

5.2.1.3    Rising geriatric population and subsequent uptake of automated dispensing systems               68

5.2.1.4    Growing focus on automation to reduce labor costs       69

5.2.1.5    Increasing demand for specialty drug dispensing            69

5.2.2        RESTRAINTS      70

5.2.2.1    High initial capital investments          70

5.2.2.2    Reluctance to adopt pharmacy automation systems       70

5.2.2.3    Shortage of skilled personnel              70

5.2.3        OPPORTUNITIES              71

5.2.3.1    Gradual shift to online pharmacy services        71

5.2.3.2    Expansion of telepharmacy & remote patient management services  71

5.2.4        CHALLENGES    72

5.2.4.1    Stringent regulatory process for automated pharmacy systems                 72

5.2.4.2    Risk of cross-contamination                72

5.2.4.3    Technical failures and system reliability issues                72

5.2.4.4    Medication dispensing risks associated with drug name selections                 73

5.3           INDUSTRY TRENDS         73

5.3.1        COMPACT SOFTWARE CONFIGURATIONS WITH MINIMAL PHYSICAL FOOTPRINTS           73

5.3.2        PHARMACY ROBOTICS FOR PRESCRIPTION DISPENSING      73

5.3.3        RFID TECHNOLOGY FOR ADVANCED MEDICATION TRACKING          74

5.3.4        CLOUD-BASED PHARMACY AUTOMATION MANAGEMENT SOLUTIONS       75

5.3.5        INTEGRATION WITH EHR FOR ENHANCED INTEROPERABILITY       75

5.3.6        ROLE OF BIG DATA IN HEALTHCARE AUTOMATION                 76

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       76

5.5           ECOSYSTEM ANALYSIS  77

5.6           VALUE CHAIN ANALYSIS               80

5.7           TECHNOLOGY ANALYSIS             82

5.7.1        KEY TECHNOLOGIES     82

5.7.1.1    Robotics 82

5.7.1.2    Robotic Process Automation (RPA) 82

5.7.2        COMPLEMENTARY TECHNOLOGIES       83

5.7.2.1    E-prescribing systems          83

5.7.2.2    EHR integration   83

5.7.2.3    Barcoding & scanning technology     83

5.7.3        ADJACENT TECHNOLOGIES       83

5.7.3.1    AI & ML 83

5.7.3.2    Telepharmacy       84

5.7.3.3    Cold chain management solutions     84

5.8           TARIFF & REGULATORY ANALYSIS           84

5.8.1        TARIFF DATA (HS CODE 9032)    84

5.8.2        TARIFF DATA (HS CODE 8422)    85

5.8.3        TARIFF DATA (HS CODE 8479)    86

5.8.4        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             87

5.8.5        REGULATORY ANALYSIS               90

5.8.5.1    North America      90

5.8.5.2    Europe   91

5.8.5.3    Asia Pacific            92

5.8.5.4    Middle East & Africa            93

5.8.5.5    Latin America       94

5.9           TRADE ANALYSIS             94

5.9.1        TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 9032)           94

5.9.2        TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 8422)           95

5.9.3        TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 8479)           96

5.10         PRICING ANALYSIS          97

5.10.1      INDICATIVE PRICE OF PHARMACY AUTOMATION, BY PRODUCT (2023)               97

5.10.2      INDICATIVE PRICE OF PHARMACY AUTOMATION DEVICES, BY REGION (2023)        98

5.11         PORTER’S FIVE FORCES ANALYSIS           99

5.11.1      INTENSITY OF COMPETITIVE RIVALRY 101

5.11.2      BARGAINING POWER OF BUYERS             101

5.11.3      THREAT OF SUBSTITUTES          101

5.11.4      THREAT OF NEW ENTRANTS      101

5.11.5      BARGAINING POWER OF SUPPLIERS       101

5.12         PATENT ANALYSIS          102

5.12.1      PATENT PUBLICATION TRENDS FOR PHARMACY AUTOMATION  102

5.12.2      JURISDICTION & TOP APPLICANT COUNTRIES FOR PHARMACY AUTOMATION          103

5.12.3      LEADING PATENTS IN PHARMACY AUTOMATION MARKET               104

5.13         KEY STAKEHOLDERS & BUYING CRITERIA            105

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           105

5.13.2      BUYING CRITERIA           106

5.14         END-USER ANALYSIS      107

5.14.1      UNMET NEEDS 107

5.14.2      END-USER EXPECTATIONS         108

5.15         KEY CONFERENCES & EVENTS, 2024–2025              109

5.16         CASE STUDY ANALYSIS 110

5.16.1      CASE STUDY 1: KING SALMAN MILITARY HOSPITAL IMPLEMENTS PHARMACY AUTOMATION             110

5.16.2      CASE STUDY 2: EVERSPRING PHARMACY AIMED TO IMPROVE EFFICIENCY IN MEDICATION DISPENSING & PACKING WITH LOW COSTS           111

5.16.3      CASE STUDY 3: MCKESSON IMPLEMENTED CLINICAL PROGRAM SOLUTIONS FOR REAL-TIME PATIENT ADHERENCE                 112

5.17         INVESTMENT & FUNDING SCENARIO     113

5.18         BUSINESS MODELS         113

5.18.1      DIRECT SALES MODEL (CAPITAL PURCHASE MODEL)                 113

5.18.2      SUBSCRIPTION-BASED MODEL (SOFTWARE-AS-A-SERVICE: SAAS) 113

5.18.3      PAY-PER-USE MODEL (TRANSACTION-BASED PRICING)                 114

5.18.4      LEASE/RENTAL MODEL                114

5.18.5      MANAGED SERVICES MODEL (OUTSOURCING & FULL-SERVICE CONTRACTS)  114

5.18.6      FREEMIUM MODEL WITH PREMIUM UPGRADES                 114

5.19         IMPACT OF AI/GENERATIVE AI ON PHARMACY AUTOMATION MARKET                115

5.19.1      KEY USE CASES 116

5.19.2      CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION         116

5.19.2.1  CASE STUDY 1: GIANT EAGLE LEVERAGES AI-DRIVEN AUTOMATION TO ENHANCE PHARMACY EFFICIENCY & PATIENT SAFETY             116

5.19.3      IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS              117

5.19.3.1  Medication management market       118

5.19.3.2  Medical robots market         118

5.19.3.3  Digital pharmacy market     118

5.19.4      USER READINESS & IMPACT ASSESSMENT            118

5.19.4.1  User readiness       118

5.19.4.1.1                User A: Hospital pharmacies              118

5.19.4.1.2                User B: Retail pharmacies  119

5.19.4.2  Impact assessment                119

5.19.4.2.1                User A: Hospital pharmacies              119

5.19.4.2.2                User B: Retail pharmacies  119

6               PHARMACY AUTOMATION MARKET, BY PRODUCT                 121

6.1           INTRODUCTION              122

6.2           AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS              123

6.2.1        ROBOTIC AUTOMATED DISPENSING SYSTEMS (ROBOTS)            125

6.2.1.1    High adoption of robots to reduce dispensing errors in hospitals to drive market      125

6.2.2        CAROUSELS        127

6.2.2.1    Improved inventory control & workflow to fuel uptake  127

6.2.3        AUTOMATED DISPENSING CABINETS (ADCS)    128

6.2.3.1    Provision of secured medication storage & drug tracking benefits to support market growth    128

6.3           AUTOMATED PACKAGING & LABELING SYSTEMS                 130

6.3.1        VIAL PACKAGING             132

6.3.1.1    Increasing demand for high-quality glass & sustainable vial packaging to drive market   132

6.3.2        POUCH PACKAGING      133

6.3.2.1    Efficient design for unit/multi-dose medication dispensing to fuel uptake             133

6.3.3        BLISTER PACKAGING     134

6.3.3.1    Rising emphasis on sustainability & smart packaging to drive market    134

6.4           AUTOMATED TABLETOP COUNTERS    135

6.4.1        GROWING FOCUS ON INCREASING OPERATING SPEED TO BOOST DEMAND      135

6.5           AUTOMATED MEDICATION COMPOUNDING SYSTEMS                 136

6.5.1        MINIMIZATION OF COMPOUNDING ERRORS AND ELIMINATION OF MEDICATION OUTSOURCING EXPENSES TO FUEL MARKET   136

6.6           PHARMACY MANAGEMENT SOFTWARE (PMS/PIMS/PIS)                 138

6.6.1        INTEGRATION OF AI FOR REGULATORY ADHERENCE TO PROPEL MARKET      138

6.7           OTHER PHARMACY AUTOMATION SYSTEMS      139

7               PHARMACY AUTOMATION MARKET, BY COMPONENT                 141

7.1           INTRODUCTION              142

7.2           HARDWARE        142

7.2.1        ABILITY TO PROVIDE RAPID EFFICIENCY WITH LOW RISK OF MANUAL MEDICATION ERRORS TO DRIVE MARKET                 142

7.3           SOFTWARE         143

7.3.1        ON-PREMISE DEPLOYMENT MODELS    145

7.3.1.1    Provision of secure, customized, and regulatory-compliant solutions for sensitive patient data to fuel uptake           145

7.3.2        CLOUD-BASED DEPLOYMENT MODELS                146

7.3.2.1    Growing focus on scalability, AI-integration, and remote accessibility to drive market                146

7.4           SERVICES             147

7.4.1        OPTIMIZATION OF PHARMACY OPERATIONS THROUGH COMPREHENSIVE AUTOMATION SERVICES TO SUPPORT MARKET GROWTH     147

8               PHARMACY AUTOMATION MARKET, BY APPLICATION                 149

8.1           INTRODUCTION              150

8.2           CENTRALIZED OPERATIONS      150

8.2.1        HIGHLY BENEFICIAL FOR LARGE HEALTHCARE FACILITIES FOR HIGH-VOLUME MEDICATION PROCESSING TO FUEL MARKET   150

8.3           DECENTRALIZED OPERATIONS                 151

8.3.1        UTILIZATION OF ADCS IN EMERGENCY DEPARTMENTS FOR REAL-TIME MEDICATION ADMINISTRATION TO PROPEL MARKET               151

9               PHARMACY AUTOMATION MARKET, BY FACILITY TYPE                 153

9.1           INTRODUCTION              154

9.2           LARGE-SCALE PHARMACIES       154

9.2.1        INTEGRATION OF AI & ML INTO COMPLEX WORKFLOWS TO FUEL UPTAKE                154

9.3           SMALL & MID-SIZED PHARMACIES           155

9.3.1        GROWING FOCUS ON OFFERING AFFORDABLE AUTOMATED SOLUTIONS TO PROPEL MARKET                155

10            PHARMACY AUTOMATION MARKET, BY END USER                 157

10.1         INTRODUCTION              158

10.2         HOSPITAL PHARMACIES               158

10.2.1      INPATIENT PHARMACIES             160

10.2.1.1  Growing need to minimize waiting times and reduce medication errors to drive market          160

10.2.2      OUTPATIENT PHARMACIES        162

10.2.2.1  Growing focus on enhancing patient convenience and complying with medication adherence to fuel market        162

10.3         AMBULATORY SURGERY CENTERS (ASCS), AMBULATORY CARE CENTERS (ACCS), AND OTHER OUTPATIENT SETTINGS               163

10.3.1      INTEGRATION OF ROBOTICS AND AI INTO AUTOMATED SOLUTIONS

TO DRIVE MARKET         163

10.4         LONG-TERM CARE AND ASSISTED LIVING FACILITIES                 164

10.4.1      EXPANSION IN GERIATRIC POPULATION TO FUEL MARKET               164

10.5         RETAIL PHARMACIES     165

10.5.1      GROWING REQUIREMENT FOR AUTOMATED TECHNOLOGY TO ASSIST WITH RAPID MEDICATION DISPENSING TO PROPEL MARKET           165

10.6         PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES               166

10.6.1      RISING FOCUS ON AUTOMATED DISPENSING FACILITIES FOR 90-DAY MEDICATION SUPPLIES TO SUPPORT MARKET GROWTH          166

11            PHARMACY AUTOMATION MARKET, BY REGION                 168

11.1         INTRODUCTION              169

11.2         NORTH AMERICA             169

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 171

11.2.2      US           175

11.2.2.1  Technological shift towards advanced pharmacy solutions to drive market          175

11.2.3      CANADA               180

11.2.3.1  Increasing uptake of AI & ML to fuel market  180

11.3         EUROPE               184

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      185

11.3.2      UK          189

11.3.2.1  Growing cases of medication errors to fuel uptake         189

11.3.3      GERMANY           193

11.3.3.1  Hub for advanced automation technologies to propel market                 193

11.3.4      FRANCE                197

11.3.4.1  Favorable government initiatives for healthcare digitization to drive market          197

11.3.5      ITALY    201

11.3.5.1  Rising focus on enhancing healthcare efficiency to support market growth       201

11.3.6      SPAIN    205

11.3.6.1  Rising uptake of ADCs for high prescription volumes to fuel uptake    205

11.3.7      REST OF EUROPE             209

11.4         ASIA PACIFIC     213

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 213

11.4.2      JAPAN   218

11.4.2.1  Incorporation of robotic dispensing systems in pharmacies to fuel market    218

11.4.3      CHINA  222

11.4.3.1  Rising need for medication safety to support market growth                 222

11.4.4      INDIA    226

11.4.4.1  Favorable digital health initiatives to propel market       226

11.4.5      REST OF ASIA PACIFIC   230

11.5         LATIN AMERICA                234

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 234

11.5.2      BRAZIL 239

11.5.2.1  High incidence of prescription errors to drive market    239

11.5.3      MEXICO                242

11.5.3.1  Growing focus on medication safety to fuel uptake        242

11.5.4      REST OF LATIN AMERICA             246

11.6         MIDDLE EAST & AFRICA                250

11.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 250

11.6.2      GCC COUNTRIES              254

11.6.2.1  Rising adoption of automation solutions to drive market                 254

11.6.3      REST OF MIDDLE EAST & AFRICA             259

12            COMPETITIVE LANDSCAPE         264

12.1         OVERVIEW          264

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            264

12.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACY AUTOMATION MARKET 265

12.3         REVENUE ANALYSIS, 2019−2023                 271

12.4         MARKET SHARE ANALYSIS, 2023                 272

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 274

12.5.1      STARS   275

12.5.2      EMERGING LEADERS     275

12.5.3      PERVASIVE PLAYERS      275

12.5.4      PARTICIPANTS 275

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         277

12.5.5.1  Company footprint               277

12.5.5.2  Region footprint   278

12.5.5.3  Product footprint  279

12.5.5.4  Component footprint           280

12.5.5.5  Application footprint            281

12.5.5.6  Facility type footprint           282

12.5.5.7  End-user footprint                283

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        284

12.6.1      PROGRESSIVE COMPANIES         284

12.6.2      RESPONSIVE COMPANIES            284

12.6.3      DYNAMIC COMPANIES  284

12.6.4      STARTING BLOCKS         284

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 286

12.6.5.1  Detailed list of key startups/SMEs    286

12.6.5.2  Competitive benchmarking of key emerging players/startups                 286

12.7         COMPANY VALUATION & FINANCIAL METRICS 287

12.7.1      FINANCIAL METRICS      287

12.7.2      COMPANY VALUATION 287

12.8         BRAND/SOFTWARE COMPARISON           288

12.9         COMPETITIVE SCENARIO             289

12.9.1      PRODUCT/SERVICE LAUNCHES                 289

12.9.2      DEALS  290

12.9.3      EXPANSIONS     292

12.9.4      OTHER DEVELOPMENTS              293

13            COMPANY PROFILES      295

13.1         KEY PLAYERS     295

13.1.1      BD          295

13.1.1.1  Business overview 295

13.1.1.2  Products/Services offered   296

13.1.1.3  Recent developments           298

13.1.1.3.1                Deals      298

13.1.1.3.2                Other developments             299

13.1.1.4  MnM view              299

13.1.1.4.1                Key strengths        299

13.1.1.4.2                Strategic choices   300

13.1.1.4.3                Weaknesses & competitive threats     300

13.1.2      OMNICELL          301

13.1.2.1  Business overview 301

13.1.2.2  Products/Services offered   303

13.1.2.3  Recent developments           306

13.1.2.3.1                Product/Service launches   306

13.1.2.3.2                Deals      307

13.1.2.3.3                Expansions             309

13.1.2.4  MnM view              309

13.1.2.4.1                Key strengths        309

13.1.2.4.2                Strategic choices   309

13.1.2.4.3                Weaknesses & competitive threats     309

13.1.3      KUKA AG (SWISSLOG HEALTHCARE)      310

13.1.3.1  Business overview 310

13.1.3.2  Products/Services offered   311

13.1.3.3  Recent developments           312

13.1.3.3.1                Product/Service launches   312

13.1.3.3.2                Deals      313

13.1.3.3.3                Other developments             314

13.1.3.4  MnM view              314

13.1.3.4.1                Key strengths        314

13.1.3.4.2                Strategic choices   314

13.1.3.4.3                Weaknesses & competitive threats     314

13.1.4      BAXTER                315

13.1.4.1  Business overview 315

13.1.4.2  Products/Services offered   317

13.1.4.3  Recent developments           318

13.1.4.3.1                Products/Service launches 318

13.1.4.3.2                Other developments             318

13.1.4.4  MnM view              319

13.1.4.4.1                Key strengths        319

13.1.4.4.2                Strategic choices   319

13.1.4.4.3                Weaknesses & competitive threats     319

13.1.5      MCKESSON CORPORATION         320

13.1.5.1  Business overview 320

13.1.5.2  Products/Services offered   321

13.1.5.3  Recent developments           322

13.1.5.3.1                Product/Service launches   322

13.1.5.3.2                Other developments             323

13.1.6      ORACLE                324

13.1.6.1  Business overview 324

13.1.6.2  Products/Services offered   326

13.1.6.3  Recent developments           327

13.1.6.3.1                Product/Service launches & enhancements     327

13.1.6.3.2                Deals      328

13.1.6.4  MnM view              328

13.1.6.4.1                Key strengths        328

13.1.6.4.2                Strategic choices   328

13.1.6.4.3                Weaknesses & competitive threats     329

13.1.7      CAPSA HEALTHCARE     330

13.1.7.1  Business overview 330

13.1.7.2  Products/Services offered   331

13.1.7.3  Recent developments           332

13.1.7.3.1                Product/Service launches & enhancements     332

13.1.7.3.2                Deals      333

13.1.7.3.3                Expansions             334

13.1.7.3.4                Other developments             334

13.1.8      YUYAMA CO., LTD.          335

13.1.8.1  Business overview 335

13.1.8.2  Products/Services offered   336

13.1.8.3  Recent developments           338

13.1.8.3.1                Product/Service launches   338

13.1.9      ARXIUM                339

13.1.9.1  Business overview 339

13.1.9.2  Products/Services offered   339

13.1.10   SCRIPTPRO, LLC               341

13.1.10.1                 Business overview 341

13.1.10.2                 Products/Services offered   342

13.1.11   RXSAFE, LLC       344

13.1.11.1                 Business overview 344

13.1.11.2                 Products/Services offered   344

13.1.11.3                 Recent developments           345

13.1.11.3.1             Deals      345

13.1.12   PEARSON MEDICAL TECHNOLOGIES, LLC            346

13.1.12.1                 Business overview 346

13.1.12.2                 Products/Services offered   346

13.1.12.3                 Recent development             347

13.1.12.3.1             Products/Service launches 347

13.1.12.3.2             Other developments             348

13.1.13   DEENOVA S.R.L.                349

13.1.13.1                 Business overview 349

13.1.13.2                 Products/Services offered   350

13.1.13.3                 Recent developments           351

13.1.13.3.1             Product/Service launches   351

13.1.13.3.2             Deals      352

13.1.13.3.3             Expansions             352

13.1.13.3.4             Other developments             353

13.1.14   MEDICAL PACKAGING INC., LLC               354

13.1.14.1                 Business overview 354

13.1.14.2                 Products/Services offered   354

13.1.14.3                 Recent developments           355

13.1.14.3.1             Product/Service launches   355

13.1.15   TENSION PACKAGING & AUTOMATION                356

13.1.15.1                 Business overview 356

13.1.15.2                 Products/Services offered   356

13.1.15.3                 Recent developments           357

13.1.15.3.1             Product/Service launches   357

13.1.15.3.2             Deals      358

13.1.15.3.3             Other developments             358

13.1.16   NORITSU PHARMACY AUTOMATION     359

13.1.16.1                 Business overview 359

13.1.16.2                 Products/Services offered   359

13.1.16.2.1             Product/Service launches   360

13.1.17   EUCLID MEDICAL PRODUCTS   361

13.1.17.1                 Business overview 361

13.1.17.2                 Products/Services offered   361

13.1.17.3                 Recent developments           362

13.1.17.3.1             Deals      362

13.1.18   TOUCHPOINT MEDICAL SOLUTIONS     363

13.1.18.1                 Business overview 363

13.1.18.2                 Products/Services offered   363

13.1.18.3                 Recent developments           364

13.1.18.3.1             Product/Service launches   364

13.1.18.3.2             Deals      365

13.1.19   INNOVATION ASSOCIATES (IA) 366

13.1.19.1                 Business overview 366

13.1.19.2                 Products/Services offered   366

13.1.19.3                 Recent developments           368

13.1.19.3.1             Product/Service launches   368

13.1.19.3.2             Deals      369

13.1.19.3.3             Expansions             369

13.1.19.3.4             Other developments             370

13.1.20   JFCRX    371

13.1.20.1                 Business overview 371

13.1.20.2                 Products/Services offered   371

13.1.20.3                 Recent developments           372

13.1.20.3.1             Product/Service launches   372

13.1.20.3.2             Deals      373

13.1.20.3.3             Expansions             373

13.2         OTHER PLAYERS              374

13.2.1      WILLACH GROUP             374

13.2.2      PHARMACY AUTOMATION SYSTEMS, LLC            375

13.2.3      ASTERES INC.    376

13.2.4      NEWLCON           377

13.2.5      ACCU-CHART PLUS HEALTH CARE SYSTEMS, INC.                 378

14            APPENDIX           380

14.1         DISCUSSION GUIDE        380

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                385

14.3         CUSTOMIZATION OPTIONS        387

14.4         RELATED REPORTS         387

14.5         AUTHOR DETAILS           388

LIST OF TABLES

TABLE 1                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                37

TABLE 2                PHARMACY AUTOMATION MARKET: FACTOR ANALYSIS            50

TABLE 3                PHARMACY AUTOMATION MARKET: RESEARCH ASSUMPTIONS  55

TABLE 4                PHARMACY AUTOMATION MARKET: RISK ASSESSMENT ANALYSIS 56

TABLE 5                PHARMACY AUTOMATION MARKET: IMPACT ANALYSIS            66

TABLE 6                KEY DEVELOPMENTS IN RFID-ENABLED PHARMACY AUTOMATION SYSTEMS      74

TABLE 7                PHARMACY AUTOMATION MARKET: ROLE IN ECOSYSTEM       79

TABLE 8                AVERAGE TARIFF FOR HS CODE 9032      84

TABLE 9                AVERAGE TARIFF FOR HS CODE 8422      85

TABLE 10              AVERAGE TARIFF FOR HS CODE 8479      86

TABLE 11              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  87

TABLE 12              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  88

TABLE 13              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  89

TABLE 14             LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  89

TABLE 15              MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             90

TABLE 16              NORTH AMERICA: REGULATORY ANALYSIS                 90

TABLE 17              EUROPE: REGULATORY ANALYSIS           91

TABLE 18              ASIA PACIFIC: REGULATORY ANALYSIS 92

TABLE 19              MIDDLE EAST & AFRICA: REGULATORY ANALYSIS            93

TABLE 20              LATIN AMERICA: REGULATORY ANALYSIS                 94

TABLE 21              HSN CODE 9032: TOP 10 IMPORTERS, BY COUNTRY,

2019−2023 (USD THOUSAND)    94

TABLE 22              HSN CODE 9032: TOP 10 EXPORTERS, BY COUNTRY,

2019−2023 (USD THOUSAND)    95

TABLE 23              HSN CODE 8422: TOP 10 IMPORTERS, BY COUNTRY,

2019−2023 (USD THOUSAND)    95

TABLE 24              HSN CODE 8422: TOP 10 EXPORTERS, BY COUNTRY,

2019−2023 (USD THOUSAND)    96

TABLE 25              HSN CODE 8479: TOP 10 IMPORTERS, BY COUNTRY,

2019−2023 (USD THOUSAND)    96

TABLE 26              HSN CODE 8479: TOP 10 EXPORTERS, BY COUNTRY,

2019−2023 (USD THOUSAND)    97

TABLE 27              AVERAGE SELLING PRICE OF PHARMACY AUTOMATION, BY PRODUCT (2023)        98

TABLE 28              INDICATIVE PRICE OF PHARMACY AUTOMATION DEVICES, BY REGION, 2023 (USD)              99

TABLE 29              PHARMACY AUTOMATION MARKET: PORTER’S FIVE FORCES ANALYSIS 100

TABLE 30              JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES

FOR PHARMACY AUTOMATION                103

TABLE 31              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS

FOR PHARMACY AUTOMATION                105

TABLE 32              KEY BUYING CRITERIA FOR PHARMACY AUTOMATION  106

TABLE 33              UNMET NEEDS IN PHARMACY AUTOMATION MARKET               107

TABLE 34              END-USER EXPECTATIONS IN PHARMACY AUTOMATION MARKET                108

TABLE 35              PHARMACY AUTOMATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS    109

TABLE 36              PHARMACY AUTOMATION MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     122

TABLE 37              KEY AUTOMATED MEDICATION DISPENSING SYSTEMS AVAILABLE     123

TABLE 38              KEY AUTOMATED MEDICATION STORAGE SYSTEMS AVAILABLE     124

TABLE 39              AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         124

TABLE 40              AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (THOUSAND UNITS)               125

TABLE 41              AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY REGION, 2022–2030 (USD MILLION)   125

TABLE 42              KEY ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE     126

TABLE 43              ROBOTIC AUTOMATED DISPENSING SYSTEMS MARKET, BY REGION,

2022–2030 (USD MILLION)            127

TABLE 44              KEY CAROUSEL SYSTEMS AVAILABLE     127

TABLE 45              CAROUSELS MARKET, BY REGION, 2022–2030 (USD MILLION) 128

TABLE 46              KEY AUTOMATED DISPENSING CABINETS AVAILABLE         129

TABLE 47              AUTOMATED DISPENSING CABINETS MARKET, BY REGION,

2022–2030 (USD MILLION)            130

TABLE 48              KEY AUTOMATED PACKAGING & LABELING SYSTEMS AVAILABLE     131

TABLE 49              AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            131

TABLE 50              AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (THOUSAND UNITS)  132

TABLE 51              AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY REGION,

2022–2030 (USD MILLION)            132

TABLE 52              VIAL PACKAGING SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION)          133

TABLE 53              POUCH PACKAGING SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION)          134

TABLE 54              BLISTER PACKAGING SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION)          134

TABLE 55              AUTOMATED TABLETOP COUNTERS MARKET, BY REGION,

2022–2030 (USD MILLION)            136

TABLE 56              KEY AUTOMATED COMPOUNDING SYSTEMS AVAILABLE         137

TABLE 57              AUTOMATED MEDICATION COMPOUNDING SYSTEMS MARKET, BY REGION,

2022–2030 (USD MILLION)            137

TABLE 58              PHARMACY MANAGEMENT SOFTWARE MARKET, BY REGION,

2022–2030 (USD MILLION)            138

TABLE 59              OTHER PHARMACY AUTOMATION SYSTEMS MARKET, BY REGION,

2022–2030 (USD MILLION)            140

TABLE 60              PHARMACY AUTOMATION MARKET, BY COMPONENT, 2022–2030 (USD MILLION)              142

TABLE 61              KEY COMPANIES AND NOTABLE PHARMACY AUTOMATION HARDWARE PRODUCTS AVAILABLE        143

TABLE 62              PHARMACY AUTOMATION MARKET FOR HARDWARE, BY REGION,

2022–2030 (USD MILLION)            143

TABLE 63              PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            144

TABLE 64              PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY REGION,

2022–2030 (USD MILLION)            145

TABLE 65              ON-PREMISE DEPLOYMENT MODELS MARKET, BY REGION,

2022–2030 (USD MILLION)            146

TABLE 66              CLOUD-BASED DEPLOYMENT MODELS MARKET, BY REGION,

2022–2030 (USD MILLION)            147

TABLE 67              PHARMACY AUTOMATION SERVICES AVAILABLE         148

TABLE 68              PHARMACY AUTOMATION MARKET FOR SERVICES, BY REGION,

2022–2030 (USD MILLION)            148

TABLE 69              PHARMACY AUTOMATION MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              150

TABLE 70              PHARMACY AUTOMATION MARKET FOR CENTRALIZED OPERATIONS, BY REGION, 2022–2030 (USD MILLION)            151

TABLE 71              PHARMACY AUTOMATION MARKET FOR DECENTRALIZED OPERATIONS, BY REGION, 2022–2030 (USD MILLION)            152

TABLE 72              PHARMACY AUTOMATION MARKET, BY FACILITY TYPE, 2022–2030 (USD MILLION)           154

TABLE 73              PHARMACY AUTOMATION MARKET FOR LARGE-SCALE PHARMACIES, BY REGION, 2022–2030 (USD MILLION)            155

TABLE 74              PHARMACY AUTOMATION MARKET FOR SMALL & MID-SIZED PHARMACIES,

BY REGION, 2022–2030 (USD MILLION)   156

TABLE 75              PHARMACY AUTOMATION MARKET, BY END USER, 2022–2030 (USD MILLION)                158

TABLE 76              HOSPITAL PHARMACIES MARKET, BY TYPE, 2022–2030 (USD MILLION)            159

TABLE 77              HOSPITAL PHARMACIES MARKET, BY REGION, 2022–2030 (USD MILLION)            159

TABLE 78              PHARMACY AUTOMATION SOLUTIONS USED FOR HOSPITAL INPATIENT PHARMACIES             160

TABLE 79              PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY REGION, 2022–2030 (USD MILLION)            161

TABLE 80              PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY REGION, 2022–2030 (USD MILLION)            162

TABLE 81              ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS MARKET, BY REGION,

2022–2030 (USD MILLION)            164

TABLE 82              PHARMACY AUTOMATION SOLUTIONS FOR LONG-TERM CARE FACILITIES  164

TABLE 83              LONG-TERM CARE AND ASSISTED LIVING FACILITIES MARKET, BY REGION,

2022–2030 (USD MILLION)            165

TABLE 84              RETAIL PHARMACIES MARKET, BY REGION, 2022–2030 (USD MILLION)            166

TABLE 85              PHARMACY AUTOMATION SOLUTIONS USED IN MAIL-ORDER PHARMACIES   167

TABLE 86              PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES MARKET, BY REGION, 2022–2030 (USD MILLION)          167

TABLE 87              PHARMACY AUTOMATION MARKET, BY REGION, 2022–2030 (USD MILLION)          169

TABLE 88              NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            171

TABLE 89              NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            172

TABLE 90              NORTH AMERICA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 172

TABLE 91              NORTH AMERICA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         173

TABLE 92              NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            173

TABLE 93              NORTH AMERICA: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         173

TABLE 94              NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            174

TABLE 95              NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            174

TABLE 96              NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            175

TABLE 97              NORTH AMERICA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            175

TABLE 98              KEY TRENDS SHAPING THE MARKET AND PHARMACIES ADOPTING THESE INNOVATIONS               176

TABLE 99              US: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     177

TABLE 100            US: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         177

TABLE 101            US: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            178

TABLE 102            US: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            178

TABLE 103            US: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            178

TABLE 104            US: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            179

TABLE 105            US: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            179

TABLE 106            US: PHARMACY AUTOMATION MARKET, BY END USER, 2022–2030 (USD MILLION)     179

TABLE 107            US: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         180

TABLE 108            KEY TRENDS AND PHARMACY INNOVATIONS IN CANADA               180

TABLE 109            CANADA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            181

TABLE 110            CANADA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 181

TABLE 111            CANADA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION)            182

TABLE 112            CANADA: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            182

TABLE 113            CANADA: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            182

TABLE 114            CANADA: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            183

TABLE 115            CANADA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            183

TABLE 116            CANADA: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            183

TABLE 117            CANADA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         184

TABLE 118            EUROPE: PHARMACY AUTOMATION MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            185

TABLE 119            EUROPE: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            186

TABLE 120            EUROPE: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 186

TABLE 121            EUROPE: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         187

TABLE 122            EUROPE: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            187

TABLE 123            EUROPE: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            187

TABLE 124            EUROPE: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            188

TABLE 125            EUROPE: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            188

TABLE 126            EUROPE: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            189

TABLE 127            EUROPE: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         189

TABLE 128            UK: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2022–2030 (USD MILLION)     190

TABLE 129            UK: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         190

TABLE 130            UK: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            191

TABLE 131            UK: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            191

TABLE 132            UK: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            191

TABLE 133            UK: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            192

TABLE 134            UK: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            192

TABLE 135            UK: PHARMACY AUTOMATION MARKET, BY END USER, 2022–2030 (USD MILLION)     192

TABLE 136            UK: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)                 193

TABLE 137            GERMANY: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            194

TABLE 138            GERMANY: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 194

TABLE 139            GERMANY: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         195

TABLE 140            GERMANY: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            195

TABLE 141            GERMANY: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         195

TABLE 142            GERMANY: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            196

TABLE 143            GERMANY: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            196

TABLE 144            GERMANY: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            196

TABLE 145            GERMANY: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES

BY END USER, 2022–2030 (USD MILLION)               197

TABLE 146            FRANCE: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            198

TABLE 147            FRANCE: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 198

TABLE 148            FRANCE: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         199

TABLE 149            FRANCE: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            199

TABLE 150            FRANCE: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            199

TABLE 151            FRANCE: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            200

TABLE 152            FRANCE: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            200

TABLE 153            FRANCE: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            200

TABLE 154            FRANCE: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         201

TABLE 155            ITALY: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            202

TABLE 156            ITALY: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         202

TABLE 157            ITALY: PHARMACY AUTOMATION MARKET FOR AUTOMATED PACKAGING AND LABELING, BY TYPE, 2022–2030 (USD MILLION) 203

TABLE 158            ITALY: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            203

TABLE 159            ITALY: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         203

TABLE 160            ITALY: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            204

TABLE 161            ITALY: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            204

TABLE 162            ITALY: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            204

TABLE 163            ITALY: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         205

TABLE 164            SPAIN: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            206

TABLE 165            SPAIN: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         206

TABLE 166            SPAIN: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            207

TABLE 167            SPAIN: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            207

TABLE 168            SPAIN: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         207

TABLE 169            SPAIN: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            208

TABLE 170            SPAIN: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            208

TABLE 171            SPAIN: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            208

TABLE 172            SPAIN: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         209

TABLE 173            REST OF EUROPE: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            210

TABLE 174            REST OF EUROPE: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 210

TABLE 175            REST OF EUROPE: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         211

TABLE 176            REST OF EUROPE: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            211

TABLE 177            REST OF EUROPE: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         211

TABLE 178            REST OF EUROPE: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            212

TABLE 179            REST OF EUROPE: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            212

TABLE 180            REST OF EUROPE: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            212

TABLE 181            REST OF EUROPE: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            213

TABLE 182            ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            215

TABLE 183            ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            215

TABLE 184            ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS, BY TYPE, 2022–2030 (USD MILLION)                 216

TABLE 185            ASIA PACIFIC: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION)            216

TABLE 186            ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            216

TABLE 187            ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         217

TABLE 188            ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            217

TABLE 189            ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            217

TABLE 190            ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            218

TABLE 191            ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         218

TABLE 192            JAPAN: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            219

TABLE 193            JAPAN: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         220

TABLE 194            JAPAN: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            220

TABLE 195            JAPAN: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            220

TABLE 196            JAPAN: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            221

TABLE 197            JAPAN: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            221

TABLE 198            JAPAN: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            221

TABLE 199            JAPAN: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            222

TABLE 200            JAPAN: HOSPITAL PHARMACIES MARKET, BY TYPE, 2022–2030 (USD MILLION)                222

TABLE 201            CHINA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            223

TABLE 202            CHINA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         223

TABLE 203            CHINA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            224

TABLE 204            CHINA: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            224

TABLE 205            CHINA: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            224

TABLE 206            CHINA: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            225

TABLE 207            CHINA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            225

TABLE 208            CHINA: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            225

TABLE 209            CHINA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            226

TABLE 210            INDIA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            227

TABLE 211            INDIA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         227

TABLE 212            INDIA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE,

2022–2030 (USD MILLION)            228

TABLE 213            INDIA: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            228

TABLE 214            INDIA: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            228

TABLE 215            INDIA: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            229

TABLE 216            INDIA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            229

TABLE 217            INDIA: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            229

TABLE 218            INDIA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)                 230

TABLE 219            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            231

TABLE 220            REST OF ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION)                231

TABLE 221            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR AUTOMATED PACKAGING AND LABELING SYSTEM, BY TYPE, 2022–2030 (USD MILLION)                 232

TABLE 222            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            232

TABLE 223            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         232

TABLE 224            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            233

TABLE 225            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE, 2022–2030 (USD MILLION)            233

TABLE 226            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            233

TABLE 227            REST OF ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            234

TABLE 228            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            235

TABLE 229            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            235

TABLE 230            LATIN AMERICA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 236

TABLE 231            LATIN AMERICA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         236

TABLE 232            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            236

TABLE 233            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY SOFTWARE,

2022–2030 (USD MILLION)            237

TABLE 234            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            237

TABLE 235            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            237

TABLE 236            LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            238

TABLE 237            LATIN AMERICA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            238

TABLE 238            BRAZIL: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            239

TABLE 239            BRAZIL: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         240

TABLE 240            BRAZIL: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 240

TABLE 241            BRAZIL: PHARMACY AUTOMATION MARKET FOR, BY COMPONENT,

2022–2030 (USD MILLION)            240

TABLE 242            BRAZIL: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            241

TABLE 243            BRAZIL: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            241

TABLE 244            BRAZIL: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            241

TABLE 245            BRAZIL: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            242

TABLE 246            BRAZIL: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES,

BY TYPE, 2022–2030 (USD MILLION)         242

TABLE 247            MEXICO: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            243

TABLE 248            MEXICO: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 243

TABLE 249            MEXICO: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         244

TABLE 250            MEXICO: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            244

TABLE 251            MEXICO: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE,

2022–2030 (USD MILLION)            244

TABLE 252            MEXICO: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            245

TABLE 253            MEXICO: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            245

TABLE 254            MEXICO: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            245

TABLE 255            MEXICO: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            246

TABLE 256            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            247

TABLE 257            REST OF LATIN AMERICA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION)                247

TABLE 258            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET FOR AUTOMATED PACKAGING & LABELING SYSTEMS AUTOMATED PACKAGING & LABELING SYSTEMS, BY TYPE, 2022–2030 (USD MILLION)    248

TABLE 259            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            248

TABLE 260            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         248

TABLE 261            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            249

TABLE 262            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE, 2022–2030 (USD MILLION)            249

TABLE 263            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY END USER, 2022–2030 (USD MILLION)            249

TABLE 264            REST OF LATIN AMERICA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            250

TABLE 265            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY REGION,

2022–2030 (USD MILLION)            251

TABLE 266            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            251

TABLE 267            MIDDLE EAST & AFRICA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION)                252

TABLE 268            MIDDLE EAST & AFRICA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 252

TABLE 269            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            252

TABLE 270            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         253

TABLE 271            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            253

TABLE 272            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE, 2022–2030 (USD MILLION)            253

TABLE 273            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            254

TABLE 274            MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY END USER, 2022–2030 (USD MILLION)                254

TABLE 275            GCC COUNTRIES: PHARMACY AUTOMATION MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            256

TABLE 276            GCC COUNTRIES: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 256

TABLE 277            GCC COUNTRIES: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET,

BY TYPE, 2022–2030 (USD MILLION)         257

TABLE 278            GCC COUNTRIES: PHARMACY AUTOMATION MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            257

TABLE 279            GCC COUNTRIES: PHARMACY AUTOMATION MARKET FOR SOFTWARE,

BY TYPE, 2022–2030 (USD MILLION)         257

TABLE 280            GCC COUNTRIES: PHARMACY AUTOMATION MARKET, BY APPLICATION,

2022–2030 (USD MILLION)            258

TABLE 281            GCC COUNTRIES: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2022–2030 (USD MILLION)            258

TABLE 282            GCC COUNTRIES: PHARMACY AUTOMATION MARKET, BY END USER,

2022–2030 (USD MILLION)            258

TABLE 283            GCC COUNTRIES: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            259

TABLE 284            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               260

TABLE 285            REST OF MIDDLE EAST & AFRICA: AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION)                260

TABLE 286            REST OF MIDDLE EAST & AFRICA: AUTOMATED PACKAGING & LABELING SYSTEMS MARKET, BY TYPE, 2022–2030 (USD MILLION) 261

TABLE 287            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET,

BY COMPONENT, 2022–2030 (USD MILLION)        261

TABLE 288            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 261

TABLE 289            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET,

BY APPLICATION, 2022–2030 (USD MILLION)       262

TABLE 290            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY FACILITY TYPE, 2022–2030 (USD MILLION)            262

TABLE 291            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET,

BY END USER, 2022–2030 (USD MILLION)               262

TABLE 292            REST OF MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR HOSPITAL PHARMACIES, BY TYPE, 2022–2030 (USD MILLION)            263

TABLE 293            OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES                265

TABLE 294            PHARMACY AUTOMATION MARKET: DEGREE OF COMPETITION           273

TABLE 295            PHARMACY AUTOMATION MARKET: REGION FOOTPRINT       278

TABLE 296            PHARMACY AUTOMATION MARKET: PRODUCT FOOTPRINT       279

TABLE 297            PHARMACY AUTOMATION MARKET: COMPONENT FOOTPRINT          280

TABLE 298            PHARMACY AUTOMATION MARKET: APPLICATION FOOTPRINT         281

TABLE 299            PHARMACY AUTOMATION MARKET: FACILITY TYPE FOOTPRINT            282

TABLE 300            PHARMACY AUTOMATION MARKET: END-USER FOOTPRINT       283

TABLE 301            PHARMACY AUTOMATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES   286

TABLE 302            PHARMACY AUTOMATION MARKET: COMPETITIVE BENCHMARKING OF

KEY EMERGING PLAYERS/STARTUPS     286

TABLE 303            PHARMACY AUTOMATION MARKET: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–JANUARY 2025     289

TABLE 304            PHARMACY AUTOMATION MARKET: DEALS, JANUARY 2021– JANUARY 2025    290

TABLE 305            PHARMACY AUTOMATION MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025         292

TABLE 306            PHARMACY AUTOMATION MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     293

TABLE 307            BD: COMPANY OVERVIEW           295

TABLE 308            BD: PRODUCTS/SERVICES OFFERED      296

TABLE 309            BD: DEALS, JANUARY 2021–JANUARY 2025                 298

TABLE 310            BD: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025    299

TABLE 311            OMNICELL: COMPANY OVERVIEW           301

TABLE 312            OMNICELL: PRODUCTS/SERVICES OFFERED                 303

TABLE 313            OMNICELL: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025     306

TABLE 314            OMNICELL: DEALS, JANUARY 2021–JANUARY 2025        307

TABLE 315            OMNICELL: EXPANSIONS, JANUARY 2021–JANUARY 2025    309

TABLE 316            KUKA AG (SWISSLOG HEALTHCARE): COMPANY OVERVIEW          310

TABLE 317            KUKA AG (SWISSLOG HEALTHCARE): PRODUCTS/SERVICES OFFERED               311

TABLE 318            KUKA AG (SWISSLOG HEALTHCARE): PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025                 312

TABLE 319            KUKA AG (SWISSLOG HEALTHCARE): DEALS, JANUARY 2021–JANUARY 2025     313

TABLE 320            KUKA AG (SWISSLOG HEALTHCARE): OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     314

TABLE 321            BAXTER: COMPANY OVERVIEW 315

TABLE 322            BAXTER: PRODUCTS/SERVICES OFFERED                 317

TABLE 323            BAXTER: PRODUCTS/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025     318

TABLE 324            BAXTER: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025         318

TABLE 325            MCKESSON CORPORATION: COMPANY OVERVIEW          320

TABLE 326            MCKESSON CORPORATION: PRODUCTS/SERVICES OFFERED               321

TABLE 327            MCKESSON CORPORATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–JANUARY 2025     322

TABLE 328            MCKESSON CORPORATION: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     323

TABLE 329            ORACLE: COMPANY OVERVIEW                324

TABLE 330            ORACLE: PRODUCTS/SERVICES OFFERED                 326

TABLE 331            ORACLE: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS,

JANUARY 2021–JANUARY 2025     327

TABLE 332            ORACLE: DEALS, JANUARY 2021–JANUARY 2025                 328

TABLE 333            CAPSA HEALTHCARE: COMPANY OVERVIEW                 330

TABLE 334            CAPSA HEALTHCARE: PRODUCTS/SERVICES OFFERED             331

TABLE 335            CAPSA HEALTHCARE: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS,

JANUARY 2021–JANUARY 2025     332

TABLE 336            CAPSA HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025    333

TABLE 337            CAPSA HEALTHCARE: EXPANSIONS, JANUARY 2021–JANUARY 2025         334

TABLE 338            CAPSA HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     334

TABLE 339            YUYAMA CO., LTD.: COMPANY OVERVIEW                 335

TABLE 340            YUYAMA CO., LTD.: PRODUCTS/SERVICES OFFERED             336

TABLE 341            YUYAMA CO., LTD.: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–JANUARY 2025     338

TABLE 342            ARXIUM: COMPANY OVERVIEW 339

TABLE 343            ARXIUM: PRODUCTS/SERVICES OFFERED                 339

TABLE 344            SCRIPTPRO, LLC: COMPANY OVERVIEW                 341

TABLE 345            SCRIPTPRO LLC: PRODUCTS/SERVICES OFFERED             342

TABLE 346            RXSAFE, LLC: COMPANY OVERVIEW       344

TABLE 347            RXSAFE, LLC: PRODUCTS/SERVICES OFFERED                 344

TABLE 348            RXSAFE, LLC: DEALS, JANUARY 2021–JANUARY 2025        345

TABLE 349            PEARSON MEDICAL TECHNOLOGIES, LLC: COMPANY OVERVIEW   346

TABLE 350            PEARSON MEDICAL TECHNOLOGIES, LLC: PRODUCTS/SERVICES OFFERED               346

TABLE 351            PEARSON MEDICAL TECHNOLOGIES, LLC: PRODUCTS/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025                 347

TABLE 352            PEARSON MEDICAL TECHNOLOGIES, LLC: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     348

TABLE 353            DEENOVA S.R.L.: COMPANY OVERVIEW 349

TABLE 354            DEENOVA S.R.L.: PRODUCTS/SERVICES OFFERED             350

TABLE 355            DEENOVA S.R.L.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025             351

TABLE 356            DEENOVA S.R.L.: DEALS, JANUARY 2021–JANUARY 2025    352

TABLE 357            DEENOVA S.R.L.: EXPANSIONS, JANUARY 2021–JANUARY 2025    352

TABLE 358            DEENOVA S.R.L.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     353

TABLE 359            MEDICAL PACKAGING INC., LLC: COMPANY OVERVIEW          354

TABLE 360            MEDICAL PACKAGING INC., LLC: PRODUCTS/SERVICES OFFERED               354

TABLE 361            MEDICAL PACKAGING INC. LLC: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–JANUARY 2025     355

TABLE 362            TENSION PACKAGING & AUTOMATION: COMPANY OVERVIEW   356

TABLE 363            TENSION PACKAGING & AUTOMATION: PRODUCTS/SERVICES OFFERED               356

TABLE 364            TENSION PACKAGING & AUTOMATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–JANUARY 2025     357

TABLE 365            TENSION PACKAGING & AUTOMATION: DEALS, JANUARY 2021–JANUARY 2025     358

TABLE 366            TENSION PACKAGING & AUTOMATION: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     358

TABLE 367            NORITSU PHARMACY AUTOMATION: COMPANY OVERVIEW   359

TABLE 368            NORITSU PHARMACY AUTOMATION: PRODUCTS/SERVICES OFFERED               359

TABLE 369            NORITSU PHARMACY AUTOMATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–JANUARY 2025     360

TABLE 370            EUCLID MEDICAL PRODUCTS: COMPANY OVERVIEW          361

TABLE 371            EUCLID MEDICAL PRODUCTS: PRODUCTS/SERVICES OFFERED               361

TABLE 372            EUCLID MEDICAL PRODUCTS: DEALS, JANUARY 2021–JANUARY 2025         362

TABLE 373            TOUCHPOINT MEDICAL SOLUTIONS: COMPANY OVERVIEW   363

TABLE 374            TOUCHPOINT MEDICAL SOLUTIONS: PRODUCTS/SERVICES OFFERED               363

TABLE 375            TOUCHPOINT MEDICAL SOLUTIONS: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025                 364

TABLE 376            TOUCHPOINT MEDICAL SOLUTIONS: DEALS, JANUARY 2021–JANUARY 2025     365

TABLE 377            INNOVATION ASSOCIATES: COMPANY OVERVIEW          366

TABLE 378            INNOVATION ASSOCIATES: PRODUCTS/SERVICES OFFERED               366

TABLE 379            INNOVATION ASSOCIATES: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025             368

TABLE 380            INNOVATION ASSOCIATES: DEALS, JANUARY 2021–JANUARY 2025         369

TABLE 381            INNOVATION ASSOCIATES: EXPANSIONS, JANUARY 2021–JANUARY 2025     369

TABLE 382            INNOVATION ASSOCIATES: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     370

TABLE 383            JFCRX: COMPANY OVERVIEW     371

TABLE 384            JFCRX: PRODUCTS/SERVICES OFFERED 371

TABLE 385            JFCRX: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025     372

TABLE 386            JFCRX: DEALS, JANUARY 2021–JANUARY 2025                 373

TABLE 387            JFCRX: EXPANSIONS, JANUARY 2021–JANUARY 2025        373

LIST OF FIGURES

FIGURE 1              PHARMACY AUTOMATION MARKET SEGMENTATION              34

FIGURE 2              RESEARCH DESIGN         39

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     44

FIGURE 4              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           45

FIGURE 5              SUPPLY-SIDE MARKET ESTIMATION      47

FIGURE 6              PHARMACY AUTOMATION MARKET: REVENUE ESTIMATION APPROACH              47

FIGURE 7              BOTTOM-UP APPROACH: END-USER SPENDING ON PHARMACY AUTOMATION  49

FIGURE 8              CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)          51

FIGURE 9              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 52

FIGURE 10            TOP-DOWN APPROACH                52

FIGURE 11            DATA TRIANGULATION METHODOLOGY                 54

FIGURE 12            PHARMACY AUTOMATION MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)               57

FIGURE 13            PHARMACY AUTOMATION MARKET, BY COMPONENT,

2024 VS. 2030 (USD MILLION)      58

FIGURE 14            PHARMACY AUTOMATION MARKET, BY APPLICATION,

2024 VS. 2030 (USD MILLION)      58

FIGURE 15            PHARMACY AUTOMATION MARKET, BY FACILITY TYPE,

2024 VS. 2030 (USD MILLION)      59

FIGURE 16            PHARMACY AUTOMATION MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)         60

FIGURE 17            GEOGRAPHIC SNAPSHOT OF PHARMACY AUTOMATION MARKET                61

FIGURE 18            RISING DEMAND FOR ERROR-FREE MEDICATION DISPENSING AND PATIENT SAFETY REGULATIONS TO PROPEL MARKET      62

FIGURE 19            HOSPITAL PHARMACIES SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2023       63

FIGURE 20            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       64

FIGURE 21            EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD          64

FIGURE 22            PHARMACY AUTOMATION MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     65

FIGURE 23            PRESCRIPTION MEDICATION USAGE BY AGE & SEX — NATIONAL HEALTH INTERVIEW SURVEY, US, 2021                 68

FIGURE 24            REVENUE SHIFT IN PHARMACY AUTOMATION MARKET               77

FIGURE 25            PHARMACY AUTOMATION MARKET: ECOSYSTEM ANALYSIS  78

FIGURE 26            PHARMACY AUTOMATION MARKET: VALUE CHAIN ANALYSIS (2023) 80

FIGURE 27            PHARMACY AUTOMATION MARKET: PORTER’S FIVE FORCES ANALYSIS 100

FIGURE 28            PATENT PUBLICATION TRENDS IN PHARMACY AUTOMATION, 2015–2025              102

FIGURE 29            JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “PHARMACY AUTOMATION” PATENTS (JANUARY 2015−JANUARY 2025)                103

FIGURE 30            TOP APPLICANT COMPANIES/INSTITUTIONS AND TOP APPLICANT COUNTRIES FOR RELATED PATENTS WERE ANALYZED FROM JANUARY 2015 TO JANUARY 2025                 104

FIGURE 31            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR

PHARMACY AUTOMATION          105

FIGURE 32            KEY BUYING CRITERIA FOR PHARMACY AUTOMATION, BY END USER     106

FIGURE 33            FUNDING IN PHARMACY AUTOMATION MARKET               113

FIGURE 34            POTENTIAL OF AI/GENERATIVE AI ON PHARMACY AUTOMATION MARKET       115

FIGURE 35            NORTH AMERICA: PHARMACY AUTOMATION MARKET SNAPSHOT       170

FIGURE 36            ASIA PACIFIC: PHARMACY AUTOMATION MARKET SNAPSHOT       214

FIGURE 37            REVENUE ANALYSIS OF KEY PLAYERS IN PHARMACY AUTOMATION MARKET, 2019–2023 (USD MILLION)                 271

FIGURE 38            MARKET SHARE ANALYSIS OF KEY PLAYERS IN

PHARMACY AUTOMATION MARKET, 2023             272

FIGURE 39            PHARMACY AUTOMATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         276

FIGURE 40            PHARMACY AUTOMATION MARKET: COMPANY FOOTPRINT       277

FIGURE 41            PHARMACY AUTOMATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 285

FIGURE 42            EV/EBITDA OF KEY VENDORS, 2025         287

FIGURE 43            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS      287

FIGURE 44            PHARMACY AUTOMATION MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS   288

FIGURE 45            BD: COMPANY SNAPSHOT (2024)              296

FIGURE 46            OMNICELL: COMPANY SNAPSHOT (2023)                 302

FIGURE 47            KUKA AG (SWISSLOG HEALTHCARE): COMPANY SNAPSHOT (2023)             311

FIGURE 48            BAXTER: COMPANY SNAPSHOT (2023)   316

FIGURE 49            MCKESSON CORPORATION: COMPANY SNAPSHOT (2024)             321

FIGURE 50            ORACLE: COMPANY SNAPSHOT (2024)   325

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• コンクリートシーラー市場 – 2030年までの世界予測 2025-04-21
• 自動車用ヒートシールド市場 – 2032年までの世界予測 2025-04-21
• XEVアフターマーケットの進化に関する競争力情報 – 2035年までの世界予測 2025-04-17
• アプリケーションライフサイクル管理市場 – 2029年までの世界予測 2025-04-17
• ヒンダードアミン光安定剤（HALS）市場 – 2030年までの世界予測 2025-04-17

MarketsandMarkets  出版レポート一覧